drugset / Trial / NCT00233532
Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The TRAIL study was conducted to examine the effects of escalating doses of an ACE inhibitor, trandolapril, on lowering blood pressure in Stage 1-2 hypertensive patients.
Timeline
- Start
- 2004-03
- Primary completion
- 2005-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | trandolapril | Small molecule | 4 mg | — |